Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric addition reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109748841B details a metal-free organocatalytic route for chiral beta-aminoketones. This method offers high enantioselectivity and cost reduction in API manufacturing.
Novel synthesis route for SGLT inhibitor intermediates ensures high purity and cost efficiency. Reliable supply chain partner for commercial scale pharmaceutical manufacturing.
Novel patent CN118184524A offers 71.1% yield for Elacestrant Intermediate 5. Asymmetric synthesis eliminates chiral resolution, ensuring cost reduction and supply reliability for pharmaceutical intermediates.
Breakthrough asymmetric cycloaddition method enables high-purity chiral heteronucleoside production with enhanced supply chain reliability and cost reduction potential.
Discover how chiral phosphoric acid catalysis enables high-yield, enantioselective synthesis of axial chiral aryl indoles for cancer drug development and supply chain de-risking.